Literature DB >> 34964873

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

Boris Draznin, Vanita R Aroda, George Bakris, Gretchen Benson, Florence M Brown, RaShaye Freeman, Jennifer Green, Elbert Huang, Diana Isaacs, Scott Kahan, Jose Leon, Sarah K Lyons, Anne L Peters, Priya Prahalad, Jane E B Reusch, Deborah Young-Hyman.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2022        PMID: 34964873     DOI: 10.2337/dc22-S011

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


  22 in total

Review 1.  Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D.

Authors:  Olga González-Albarrán; Cristóbal Morales; Manuel Pérez-Maraver; José Juan Aparicio-Sánchez; Rafael Simó
Journal:  Diabetes Ther       Date:  2022-06-15       Impact factor: 3.595

Review 2.  Diabetes: how to manage chronic kidney disease.

Authors:  Jennifer N Clements
Journal:  Drugs Context       Date:  2022-06-14

Review 3.  Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Wujisiguleng Bao; Mingzhu Zhang; Ning Li; Zhi Yao; Luying Sun
Journal:  Eur J Clin Pharmacol       Date:  2022-10-22       Impact factor: 3.064

4.  The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19).

Authors:  Gemma Llauradó; Bogdan Vlacho; Matthieu Wargny; Yue Ruan; Dídac Mauricio; Josep Franch-Nadal; Pere Domingo; Pierre Gourdy; Pierre-Jean Saulnier; Samy Hadjadj; Sarah H Wild; Rustam Rea; Bertrand Cariou; Kamlesh Khunti
Journal:  Cardiovasc Diabetol       Date:  2022-10-19       Impact factor: 8.949

Review 5.  Clinical perspective-evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes.

Authors:  Peter Rossing
Journal:  Kidney Int Suppl (2011)       Date:  2022-03-18

Review 6.  Novel Markers in Diabetic Kidney Disease-Current State and Perspectives.

Authors:  Agnieszka Piwkowska; Łukasz Zdrojewski; Zbigniew Heleniak; Alicja Dębska-Ślizień
Journal:  Diagnostics (Basel)       Date:  2022-05-11

Review 7.  Integrating CKD Into US Primary Care: Bridging the Knowledge and Implementation Gaps.

Authors:  Joseph A Vassalotti; Suelyn C Boucree
Journal:  Kidney Int Rep       Date:  2022-02-04

8.  Aldosterone-to-Renin Ratio Is Associated with Diabetic Nephropathy in Type 2 Diabetic Patients: A Single-Center Retrospective Study.

Authors:  Mariko Higa; Takamasa Ichijo; Takahisa Hirose
Journal:  Med Sci Monit       Date:  2022-03-20

Review 9.  An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.

Authors:  Teresa Salvatore; Raffaele Galiero; Alfredo Caturano; Luca Rinaldi; Anna Di Martino; Gaetana Albanese; Jessica Di Salvo; Raffaella Epifani; Raffaele Marfella; Giovanni Docimo; Miriam Lettieri; Celestino Sardu; Ferdinando Carlo Sasso
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

Review 10.  Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus.

Authors:  Jin Yu; Seung-Hwan Lee; Mee Kyoung Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.